- Home
- ALGS vs CFSB Comparison
ALGS vs CFSB Comparison
Compare ALGS & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- CFSB
- Stock Information
- Founded
- ALGS 2018
- CFSB 1889
- Country
- ALGS United States
- CFSB United States
- Employees
- ALGS N/A
- CFSB N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- ALGS Health Care
- CFSB Finance
- Exchange
- ALGS Nasdaq
- CFSB Nasdaq
- Market Cap
- ALGS 38.8M
- CFSB 44.9M
- IPO Year
- ALGS 2020
- CFSB N/A
- Fundamental
- Price
- ALGS $7.14
- CFSB $7.63
- Analyst Decision
- ALGS Strong Buy
- CFSB
- Analyst Count
- ALGS 1
- CFSB 0
- Target Price
- ALGS $70.00
- CFSB N/A
- AVG Volume (30 Days)
- ALGS 140.5K
- CFSB 4.2K
- Earning Date
- ALGS 03-10-2025
- CFSB 04-28-2025
- Dividend Yield
- ALGS N/A
- CFSB N/A
- EPS Growth
- ALGS N/A
- CFSB N/A
- EPS
- ALGS N/A
- CFSB N/A
- Revenue
- ALGS $3,945,000.00
- CFSB $7,462,000.00
- Revenue This Year
- ALGS $580.86
- CFSB N/A
- Revenue Next Year
- ALGS N/A
- CFSB N/A
- P/E Ratio
- ALGS N/A
- CFSB N/A
- Revenue Growth
- ALGS N/A
- CFSB N/A
- 52 Week Low
- ALGS $6.76
- CFSB $6.34
- 52 Week High
- ALGS $46.80
- CFSB $8.28
- Technical
- Relative Strength Index (RSI)
- ALGS 24.28
- CFSB 47.64
- Support Level
- ALGS $10.45
- CFSB $7.58
- Resistance Level
- ALGS $9.76
- CFSB $8.05
- Average True Range (ATR)
- ALGS 1.11
- CFSB 0.16
- MACD
- ALGS 0.15
- CFSB 0.00
- Stochastic Oscillator
- ALGS 2.13
- CFSB 16.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.